healthcare stock

$ISRG has averaged 21% annual gains over the past decade. Robotic surgery procedures grew 18% YoY, positioning the stock as a potential long-term wealth builder despite premium valuations.

Johnson & Johnson shares dropped under 2% as S&P 500 fell 7%, backed by $94.2B revenue, 6% growth, and 63 consecutive dividend increases, though talc lawsuits and Medicare price negotiations pose headwinds.